/
BIOC
$0.43-$0.07 (-13.05%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Price (6 mo)
Loading chart…
Change$-129.77
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $609.9K | $3.2M | $5.1M | $3.3M | $5.5M | $27.5M | $61.2M | $25.9M |
| Cost of revenue | $4.6M | $6.9M | $9.3M | $10.1M | $11.0M | $21.3M | $37.8M | $28.4M |
| Gross profit | −$4.0M | −$3.7M | −$4.3M | −$6.8M | −$5.4M | $6.1M | $23.5M | −$2.6M |
| Gross margin | -653.6% | -114.7% | -84.4% | -209.3% | -98.6% | 22.3% | 38.3% | -10.0% |
| R&D | $2.9M | $2.7M | $3.4M | $4.5M | $4.7M | $5.2M | $5.0M | $6.2M |
| Operating income | −$16.4M | −$18.0M | −$21.2M | −$24.3M | −$23.1M | −$15.5M | −$2.4M | −$32.0M |
| EBITDA | −$16.4M | −$18.0M | −$21.2M | −$24.3M | −$23.1M | −$14.5M | −$2.4M | −$30.3M |
| Net income | −$16.9M | −$18.4M | −$21.6M | −$24.6M | −$24.6M | −$17.0M | −$2.8M | −$32.1M |
| Net margin | -2779.0% | -570.9% | -426.4% | -756.0% | -445.2% | -62.1% | -4.6% | -124.1% |
| EPS (diluted) | -23282.32 | -17292.60 | -7074.87 | -2634.46 | -357.41 | -43.16 | -5.73 | -56.78 |
Annual figures · source: Financial Modeling Prep
Peer comparison
Held by traders on TradeandTell
No one on the platform currently holds BIOC.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in BIOC as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2023-05-17 | 1-for-30reverse |
| 2020-09-08 | 1-for-10reverse |
| 2018-07-10 | 1-for-30reverse |
| 2016-09-29 | 1-for-3reverse |
| 2005-02-07 | 1-for-200reverse |
Recent trades on TradeandTell
No one on the platform has traded BIOC yet.